Holista Colltech Ltd has released a press release.
Pause in Trade
Filed with ASX ·
On 6ix: 6ix.com/news/pause-in-trade-76
6ix hasn’t read this filing yet.
Holista Colltech Limited on 6ix
In the deck
Earlier from Holista Colltech
- HCT to Co-Develop Nasal Sanitising Balm and Extend NatShield
- Response to ASX Price and Volume Query
- Controlled Placement Agreement & Share Issue
- Increase in shipments for Natshield and Aust bottling plans
- Natshield Nasal Balm with Path-Away as Viruses Barrier
Later from Holista Colltech
- Retraction of Statements and Clarification
- Dr Arthur Martin joins Scientific Advisory Board
- Letter of confirmation towards global distribution rights
- Maiden Sales of $1.4M for 80Less Sugar Formulation
- Commencement of tests in UK Lab of Pathaway
Follow Holista Colltech into a list and get an email when it puts out news.
Follow Holista Colltech